等待开盘 12-16 09:30:00 美东时间
-0.350
-1.42%
Mirion Technologies Inc's (NYSE:MIR) short interest as a percent of float has r...
12-15 23:01
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
12-09 10:32
Citigroup analyst Andrew Kaplowitz maintains Mirion Technologies (NYSE:MIR) with a Buy and lowers the price target from $35 to $33.
12-09 03:25
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
11-26 10:07
Evercore ISI Group analyst Nicholas Amicucci initiates coverage on Mirion Technologies (NYSE:MIR) with a Outperform rating and announces Price Target of $29.
11-25 20:51
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25
JP Morgan analyst Tomohiko Sano maintains Mirion Technologies (NYSE:MIR) with a Overweight and raises the price target from $28 to $34.
10-31 05:04
今年来,美的频频的回购动作可以说是资本市场一道颇为亮丽的风景线。自2025年4月启动回购以来,几乎每个交易日都在稳步推进这一计划,展现出极强的执行力和资金实力...
10-30 15:58
Mirion Technologies (NYSE:MIR) affirms FY2025 Adj EPS guidance from $0.48-$0.52 to $0.48-$0.52 vs $0.48 analyst estimate. Affirms FY2025 sales outlook from $921.056 million-$938.272 million to $921.056 million-$938.272
10-29 04:19